Increase of O-Glycosylated Oncofetal Fibronectin in High Glucose-Induced Epithelial-Mesenchymal Transition of Cultured Human Epithelial Cells

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Alisson Silva, Frederico ^a   Freire de Lima, Leonardo ^a   Donadio, Joana L ^a   Lucena, Miguel C ^a   Penha, Luciana ^a   Sá Diniz, Julliana N ^a   Dias, Wagner B ^a   Todeschini, Adriane R ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; GLUCOSE; GLUTAMINE FRUCTOSE 6 PHOSPHATE AMINOTRANSFERASE; HEXOSAMINE; MESSENGER RNA; ONCOFETAL ANTIGEN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CARCINOGENESIS; CELL MOTILITY; CELL STRUCTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN GLYCOSYLATION; PROTEIN SECRETION; PROTEIN SYNTHESIS; UPREGULATION;

AMINO ACID SEQUENCE; BIOLOGICAL MARKERS; CELL LINE, TUMOR; CELL MOVEMENT; CELL SHAPE; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; FIBRONECTINS; GLUCOSE; GLYCOSYLATION; HEXOSAMINES; HUMANS; HYPERGLYCEMIA; MESODERM; MOLECULAR SEQUENCE DATA; NITROGENOUS GROUP TRANSFERASES; PEPTIDES; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84876084149     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060471     Document Type: Article

References (44)

1. Wellen KE, Thompson CB, (2012) A two-way street: reciprocal regulation of metabolism and signalling. Nat Rev Mol Cell Biol 13: 270-276.
2. Warburg O, (1956) On respiratory impairment in cancer cells. Science 124: 269-270.
3. Hsu PP, Sabatini DM, (2008) Cancer cell metabolism: Warburg and beyond. Cell 134: 703-707.
4. Vander Heiden MG, Cantley LC, Thompson CB, (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324: 1029-1033.
5. Brownlee M, (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820.
6. Freeze HH, Elbein AD (2009) Glycosylation Precursors.
7. Dennis JW, Nabi IR, Demetriou M, (2009) Metabolism, cell surface organization, and disease. Cell 139: 1229-1241.
8. Hakomori S, (2002) Glycosylation defining cancer malignancy: new wine in an old bottle. Proc Natl Acad Sci U S A 99: 10231-10233.
9. Lau KS, Dennis JW, (2008) N-Glycans in cancer progression. Glycobiology 18: 750-760.
10. Slawson C, Hart GW, (2011) O-GlcNAc signalling: implications for cancer cell biology. Nat Rev Cancer 11: 678-684.
11. Thiery JP, Acloque H, Huang RY, Nieto MA, (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139: 871-890.
12. Guan F, Handa K, Hakomori SI, (2009) Specific glycosphingolipids mediate epithelial-to-mesenchymal transition of human and mouse epithelial cell lines. Proc Natl Acad Sci U S A 106: 7461-7466.
13. Hakomori SI, (2010) Glycosynaptic microdomains controlling tumor cell phenotype through alteration of cell growth, adhesion, and motility. FEBS Lett 584: 1901-1906.
14. Park JH, Katagiri T, Chung S, Kijima K, Nakamura Y, (2011) Polypeptide N-acetylgalactosaminyltransferase 6 disrupts mammary acinar morphogenesis through O-glycosylation of fibronectin. Neoplasia 13: 320-326.
15. Zhang H, Meng F, Wu S, Kreike B, Sethi S, et al. (2011) Engagement of I-branching {beta}-1, 6-N-acetylglucosaminyltransferase 2 in breast cancer metastasis and TGF-{beta} signaling. Cancer Res 71: 4846-4856.
16. Park SY, Kim HS, Kim NH, Ji S, Cha SY, et al. (2010) Snail1 is stabilized by O-GlcNAc modification in hyperglycaemic condition. EMBO J 29: 3787-3796.
17. Kalluri R, Weinberg RA, (2009) The basics of epithelial-mesenchymal transition. J Clin Invest 119: 1420-1428.
18. Singh P, Carraher C, Schwarzbauer JE, (2010) Assembly of fibronectin extracellular matrix. Annu Rev Cell Dev Biol 26: 397-419.
19. White ES, Muro AF, (2011) Fibronectin splice variants: understanding their multiple roles in health and disease using engineered mouse models. IUBMB Life 63: 538-546.
20. Mosher DF, (2001) A role for fibronectin in self-repair after ischemic injury. Nat Med 7: 290-292.
21. Bennett EP, Hassan H, Mandel U, Hollingsworth MA, Akisawa N, et al. (1999) Cloning and characterization of a close homologue of human UDP-N-acetyl-alpha-D-galactosamine:Polypeptide N-acetylgalactosaminyltransferase-T3, designated GalNAc-T6. Evidence for genetic but not functional redundancy. J Biol Chem 274: 25362-25370.
22. Freire-de-Lima L, Gelfenbeyn K, Ding Y, Mandel U, Clausen H, et al. (2011) Involvement of O-glycosylation defining oncofetal fibronectin in epithelial-mesenchymal transition process. Proc Natl Acad Sci U S A 108: 17690-17695.
23. Matsuura H, Hakomori S, (1985) The oncofetal domain of fibronectin defined by monoclonal antibody FDC-6: its presence in fibronectins from fetal and tumor tissues and its absence in those from normal adult tissues and plasma. Proc Natl Acad Sci U S A 82: 6517-6521.
24. Dias WB, Cheung WD, Wang Z, Hart GW, (2009) Regulation of calcium/calmodulin-dependent kinase IV by O-GlcNAc modification. J Biol Chem 284: 21327-21337.
25. Matsuura H, Greene T, Hakomori S, (1989) An alpha-N-acetylgalactosaminylation at the threonine residue of a defined peptide sequence creates the oncofetal peptide epitope in human fibronectin. J Biol Chem 264: 10472-10476.
26. Zaman MH, Trapani LM, Sieminski AL, Mackellar D, Gong H, et al. (2006) Migration of tumor cells in 3D matrices is governed by matrix stiffness along with cell-matrix adhesion and proteolysis. Proc Natl Acad Sci U S A 103: 10889-10894.
27. Todeschini AR, Dos Santos JN, Handa K, Hakomori SI, (2007) Ganglioside GM2-tetraspanin CD82 complex inhibits met and its cross-talk with integrins, providing a basis for control of cell motility through glycosynapse. J Biol Chem 282: 8123-8133.
28. Todeschini AR, Dos Santos JN, Handa K, Hakomori SI, (2008) Ganglioside GM2/GM3 complex affixed on silica nanospheres strongly inhibits cell motility through CD82/cMet-mediated pathway. Proc Natl Acad Sci U S A 105: 1925-1930.
29. Schofield KP, Humphries MJ, (1999) Identification of fibronectin IIICS variants in human bone marrow stroma. Blood 93: 410-411.
30. Kolm-Litty V, Sauer U, Nerlich A, Lehmann R, Schleicher ED, (1998) High glucose-induced transforming growth factor beta1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells. J Clin Invest 101: 160-169.
31. Schofield KP, Humphries MJ, (1999) Identification of fibronectin IIICS variants in human bone marrow stroma. Blood 93: 410-411.
32. Zhou L, Xue H, Yuan P, Ni J, Yu C, et al. (2010) Angiotensin AT1 receptor activation mediates high glucose-induced epithelial-mesenchymal transition in renal proximal tubular cells. Clin Exp Pharmacol Physiol 37: e152-157.
33. Ding Y, Gelfenbeyn K, Freire-de-Lima L, Handa K, Hakomori SI, (2012) Induction of epithelial-mesenchymal transition with O-glycosylated oncofetal fibronectin. FEBS Lett 586: 1813-1820.
34. Barnes JL, Gorin Y, (2011) Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases. Kidney Int 79: 944-956.
35. Labat-Robert J, (2012) Cell-Matrix interactions, the role of fibronectin and integrins. A survey. Pathol Biol (Paris) 60: 15-19.
36. Nomoto M, Izumi H, Ise T, Kato K, Takano H, et al. (1999) Structural basis for the regulation of UDP-N-acetyl-alpha-D-galactosamine: polypeptide N-acetylgalactosaminyl transferase-3 gene expression in adenocarcinoma cells. Cancer Res 59: 6214-6222.
37. Tarp MA, Clausen H, (2008) Mucin-type O-glycosylation and its potential use in drug and vaccine development. Biochim Biophys Acta 1780: 546-563.
38. Vigneri R, (2009) Diabetes: diabetes therapy and cancer risk. Nat Rev Endocrinol 5: 651-652.
39. Kang SP, Saif MW, (2010) Clinical outcome of pancreatic cancer patients with diabetes mellitus: is diabetes a poor prognostic factor? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010. JOP 11: 334-335.
40. King TE Jr, Pardo A, Selman M, (2011) Idiopathic pulmonary fibrosis. Lancet 378: 1949-1961.
41. Gribbin J, Hubbard R, Smith C, (2009) Role of diabetes mellitus and gastro-oesophageal reflux in the aetiology of idiopathic pulmonary fibrosis. Respir Med 103: 927-931.
42. Kim KK, Kugler MC, Wolters PJ, Robillard L, Galvez MG, et al. (2006) Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc Natl Acad Sci U S A 103: 13180-13185.
43. Weigert C, Brodbeck K, Sawadogo M, Haring HU, Schleicher ED, (2004) Upstream stimulatory factor (USF) proteins induce human TGF-beta1 gene activation via the glucose-response element-1013/-1002 in mesangial cells: up-regulation of USF activity by the hexosamine biosynthetic pathway. J Biol Chem 279: 15908-15915.
44. Dias WB, Cheung WD, Hart GW, (2012) O-GlcNAcylation of kinases. Biochem Biophys Res Commun 422: 224-8.